{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:28:58Z","timestamp":1790051338845,"version":"4.0.1"},"reference-count":20,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Introduction of the nanobody caplacizumab was shown to be effective in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in the acute setting. The official recommendations include plasma exchange (PEX), immunosuppression, and the use of caplacizumab for a minimum of 30 days after stopping daily PEX. This study was a retrospective, observational analysis of the use of caplacizumab in 60 patients from 29 medical centers in Germany. Immunosuppressive treatment led to a rapid normalization of ADAMTS13 activities (calculated median, 21 days). In 35 of 60 patients, ADAMTS13 activities started to normalize before day 30 after PEX; in 11 of 60 patients, the treatment was extended beyond day 30; and in 5 patients, it was extended even beyond day 58 due to persistent autoimmune activity. In 34 of 60 instances, caplacizumab was stopped before day 30 with a favorable outcome whenever ADAMTS13 activities were &amp;gt;10%. In contrast, 11 of 34 patients with ADAMTS13 activities &amp;lt;10% at the time of stopping caplacizumab treatment developed a nonfavorable outcome (disease exacerbation or relapse). In some cases, prolongation of the treatment interval to every other day was feasible and resulted in a sustained reduction of von Willebrand factor activity. ADAMTS13 activity measurements are central for a rapid diagnosis in the acute setting but also to tailor disease management. An ADAMTS13 activity\u2013guided approach seems safe for identifying the individual time point when to stop caplacizumab to prevent overtreatment and undertreatment; this approach will result in significant cost savings without jeopardizing the well-being of patients. In addition, von Willebrand factor activity may serve as a biomarker for drug monitoring.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001987","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T12:12:38Z","timestamp":1594123958000},"page":"3093-3101","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":76,"title":["ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-6128","authenticated-orcid":false,"given":"Linus A.","family":"V\u00f6lker","sequence":"first","affiliation":[{"name":"Department II of Internal Medicine\u2013Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine\u2013University Hospital Cologne, Cologne, Germany;"},{"name":"Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kaufeld","sequence":"first","affiliation":[{"name":"Department of Nephrology and Hypertension, Medical School Hannover, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Miesbach","sequence":"first","affiliation":[{"name":"Department of Haemostaseology and Haemophilia Center, University Hospital Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Br\u00e4hler","sequence":"first","affiliation":[{"name":"Department II of Internal Medicine\u2013Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine\u2013University Hospital Cologne, Cologne, Germany;"},{"name":"Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7862-0993","authenticated-orcid":false,"given":"Martin","family":"Reinhardt","sequence":"first","affiliation":[{"name":"Department of Nephrology and Hypertension, Medical School Hannover, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"K\u00fchne","sequence":"first","affiliation":[{"name":"Department II of Internal Medicine\u2013Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine\u2013University Hospital Cologne, Cologne, Germany;"},{"name":"Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"M\u00fchlfeld","sequence":"first","affiliation":[{"name":"Division of Nephrology & Clinical Immunology, Uniklinik RWTH Aachen, Aachen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Schreiber","sequence":"first","affiliation":[{"name":"Department of Nephrology\u2013Intensive Care Medicine, Berlin, Charit\u00e9\u2013Universit\u00e4tsmedizin, Berlin, Germany;"},{"name":"Experimental and Clinical Research Center, Charit\u00e9, Max Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Gaedeke","sequence":"first","affiliation":[{"name":"Department of Nephrology\u2013Intensive Care Medicine, Berlin, Charit\u00e9\u2013Universit\u00e4tsmedizin, Berlin, Germany;"},{"name":"Experimental and Clinical Research Center, Charit\u00e9, Max Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9843-2132","authenticated-orcid":false,"given":"Markus","family":"T\u00f6lle","sequence":"first","affiliation":[{"name":"Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt Universit\u00e4t zu Berlin, and"},{"name":"Department of Nephrology and Intensive Care Medicine, Berlin Institute of Health, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram J.","family":"Jabs","sequence":"first","affiliation":[{"name":"Department of Nephrology, Vivantes Klinikum im Friedrichshain, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedai","family":"\u00d6zcan","sequence":"first","affiliation":[{"name":"Department of Nephrology and Emergency Medicine, Klinikum Dortmund, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Markau","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, Martin Luther University Halle-Wittenberg, Halle, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2823-0847","authenticated-orcid":false,"given":"Matthias","family":"Girndt","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, Martin Luther University Halle-Wittenberg, Halle, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Bauer","sequence":"first","affiliation":[{"name":"Medical Department I, Marien Hospital Herne, Ruhr-University of Bochum, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timm H.","family":"Westhoff","sequence":"first","affiliation":[{"name":"Medical Department I, Marien Hospital Herne, Ruhr-University of Bochum, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Felten","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Nephrology, Rheumatology, and Pneumology, Karlsruhe General Hospital, Karlsruhe, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hausberg","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Nephrology, Rheumatology, and Pneumology, Karlsruhe General Hospital, Karlsruhe, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Brand","sequence":"first","affiliation":[{"name":"Department of Internal Medicine D, University of M\u00fcnster, Muenster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Gerth","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, Heinrich Braun Klinikum Zwickau, Zwickau, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bieringer","sequence":"first","affiliation":[{"name":"Department of Cardiology and Nephrology, Helios Klinik Berlin-Buch, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bommer","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (Hematology, Oncology, Palliative Care and Infectious Diseases), Alb-Fils-Kliniken, G\u00f6ppingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zschiedrich","sequence":"first","affiliation":[{"name":"Department of Nephrology and Primary Care, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0661-6984","authenticated-orcid":false,"given":"Johanna","family":"Schneider","sequence":"first","affiliation":[{"name":"Department of Nephrology and Primary Care, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saban","family":"Elitok","sequence":"first","affiliation":[{"name":"Department of Nephrology and Endocrinology\/Diabetology Potsdam, Klinikum Ernst von Bergmann, Potsdam, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gawlik","sequence":"first","affiliation":[{"name":"Department of Nephrology and Endocrinology\/Diabetology Potsdam, Klinikum Ernst von Bergmann, Potsdam, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"G\u00e4ckler","sequence":"first","affiliation":[{"name":"Department of Nephrology, University Hospital Essen, University Essen-Duisburg, Essen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kribben","sequence":"first","affiliation":[{"name":"Department of Nephrology, University Hospital Essen, University Essen-Duisburg, Essen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedat","family":"Schwenger","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hypertension, and Autoimmune Disorders, Klinikum Stuttgart, Stuttgart, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Schoenermarck","sequence":"first","affiliation":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen\u2013Medizinische Klinik und Poliklinik IV, Nephrologisches Zentrum, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Roeder","sequence":"first","affiliation":[{"name":"Section of Nephrology, Medical Clinic I, Klinikum Landshut, Landshut, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Radermacher","sequence":"first","affiliation":[{"name":"Center for Internal Medicine\/Nephrology, Johannes Wesling Klinikum Minden, Ruhr-University of Bochum, Minden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Bramstedt","sequence":"first","affiliation":[{"name":"Clinic of Cardiology, Nephrology, and Intensive Care, Bremerhaven, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Morgner","sequence":"first","affiliation":[{"name":"Klinikum Chemnitz GmbH, Department of Internal Medicine III, Chemnitz, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Herbst","sequence":"first","affiliation":[{"name":"Klinikum Chemnitz GmbH, Department of Internal Medicine III, Chemnitz, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Harth","sequence":"first","affiliation":[{"name":"Department of Nephrology, Transplantation, and Medical Intensive Care, University Witten\/Herdecke, Medical Centre Cologne-Merheim, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian A.","family":"Potthoff","sequence":"first","affiliation":[{"name":"Klinikum Chemnitz GmbH, Department of Internal Medicine III, Chemnitz, Germany;"},{"name":"Department of Nephrology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"von Auer","sequence":"first","affiliation":[{"name":"Department of Hematology, Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Rheinland-Pfalz, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1600-6581","authenticated-orcid":false,"given":"Ralph","family":"Wendt","sequence":"first","affiliation":[{"name":"Department of Nephrology and Kuratorium for Dialysis\u2013Transplantation Renal Unit, Hospital St. Georg, Leipzig, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3235-2994","authenticated-orcid":false,"given":"Hildegard","family":"Christ","sequence":"first","affiliation":[{"name":"Institute of Medical Statistics and Computational Biology, University Hospital of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4287-2080","authenticated-orcid":false,"given":"Paul T.","family":"Brinkkoetter","sequence":"first","affiliation":[{"name":"Department II of Internal Medicine\u2013Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine\u2013University Hospital Cologne, Cologne, Germany;"},{"name":"Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Menne","sequence":"first","affiliation":[{"name":"Department of Nephrology and Hypertension, Medical School Hannover, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"issue":"5","key":"2020070711401041900_B1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.2019000954","article-title":"How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns","volume":"134","author":"Mazepa","year":"2019","journal-title":"Blood"},{"issue":"13","key":"2020070711401041900_bib22","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/bloodadvances.2020001973","article-title":"Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura","volume":"4","author":"V\u00f6lker","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"2020070711401041900_B2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"2020070711401041900_B3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"},{"key":"2020070711401041900_B4","article-title":"Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab","author":"Sukumar","year":"2020","journal-title":"Am. J. Hematol"},{"issue":"1","key":"2020070711401041900_B5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMc1905426","article-title":"Caplacizumab therapy without plasma exchange for acquired thrombotic thrombocytopenic purpura","volume":"381","author":"Chander","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"2020070711401041900_B6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1537-2995.2008.02060.x","article-title":"ADAMTS13: what it does, how it works, and why it\u2019s important","volume":"49","author":"George","year":"2009","journal-title":"Transfusion"},{"issue":"4","key":"2020070711401041900_B7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjh.12569","article-title":"Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP)","volume":"163","author":"Shah","year":"2013","journal-title":"Br J Haematol"},{"key":"2020070711401041900_B8","first-page":"15","article-title":"Management of thrombotic thrombocytopenic purpura: current perspectives","volume":"5","author":"Blombery","year":"2014","journal-title":"J Blood Med"},{"issue":"4","key":"2020070711401041900_B9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2141.2006.06471.x","article-title":"The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura","volume":"136","author":"Starke","year":"2007","journal-title":"Br J Haematol"},{"issue":"11","key":"2020070711401041900_B10","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"issue":"2","key":"2020070711401041900_B13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2020070711401041900_B20","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/cc5952","article-title":"A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units","volume":"11","author":"Moerer","year":"2007","journal-title":"Crit Care"},{"key":"2020070711401041900_B21","unstructured":"Fallpauschalen-Katalog. 2020, InEK GmbH. https:\/\/www.g-drg.de\/G-DRG-System_2020\/Fallpauschalen-Katalog\/Fallpauschalen-Katalog_2020. Accessed 22 April 2020"},{"issue":"3","key":"2020070711401041900_B14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jth.12114","article-title":"Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse","volume":"11","author":"Westwood","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2020070711401041900_B15","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1055\/s-0039-1696718","article-title":"Evaluation of a new, rapid, fully automated assay for the measurement of ADAMTS13 activity","volume":"119","author":"Valsecchi","year":"2019","journal-title":"Thromb Haemost"},{"issue":"1","key":"2020070711401041900_B16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/CCM.0b013e31822e9d66","article-title":"Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange","volume":"40","author":"Froissart","year":"2012","journal-title":"Crit Care Med"},{"issue":"7","key":"2020070711401041900_B17","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2011-03-341131","article-title":"A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura","volume":"118","author":"Scully","year":"2011","journal-title":"Blood"},{"issue":"21","key":"2020070711401041900_B18","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2020070711401041900_B19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13023-019-1240-0","article-title":"Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study","volume":"14","author":"Miesbach","year":"2019","journal-title":"Orphanet J Rare Dis"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/13\/3093\/1748166\/advancesadv2020001987.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/13\/3093\/1748166\/advancesadv2020001987.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T12:13:04Z","timestamp":1594123984000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/13\/3093\/461269\/ADAMTS13-and-VWF-activities-guide-individualized"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":20,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001987","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]}}}